NanoSpy, Inc.
Ames
About NanoSpy, Inc.
NanoSpy, Inc. was founded in 2017 to establish the new state-of-the-art in rapid pathogen detection. Using proprietary and patent-pending technologies, we leverage our expertise in biomedical engineering, microbiology, nanomaterials, and mechanical engineering to dramatically simplify the detection process with a new paradigm in biosensor platforms. Sensitivity, specificity, and speed now are combined in one convenient test that delivers results fast! In 20 minutes, NanoSpy biosensors can detect a single targeted pathogen at 5 CFU/mL or less from common buffer samples taken right at the point of detection. No time-consuming enrichment process. No environmentally hazardous reagents. No laboratory requirements. Translation: No time wasted. No decisions delayed.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $306.0K
- Last round: Grant (Jun 2022)
- Website: nanospyinc.com
- Phone: 312-550-1584
Industries & Categories
Biotechnology, Food and Beverage, Food Processing, Health Care
Social Profiles
Canonical: https://fsome.com/organization/nanospy-inc-52483 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.